Regeneron Pharmaceuticals (REGN) Stock Chart & Stock Price History → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free REGN Stock Alerts $1,007.74 +6.01 (+0.60%) (As of 03:56 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Regeneron Pharmaceuticals Stock Price Performance5 Day Performance+0.09%1 Month Performance+2.87%3 Month Performance+3.87%6 Month Performance+18.07%Year-To-Date Performance+14.05%1 Year Performance+34.19% Receive REGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Oasis GoldExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.Click Here To Get Your FREE Guide Now! REGN Stock Chart for Tuesday, June, 11, 2024 REGN Chart by TradingView Regeneron Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/10/2024$1,002.95$1,001.73-0.12%$1,002.95$992.22250,881 shs$110.38 billion06/07/2024$1,000.79$1,002.95+0.22%$1,006.95$994.44250,077 shs$110.52 billion06/06/2024$1,005.87$1,000.79-0.51%$1,016.00$997.73439,731 shs$110.28 billion06/05/2024$993.29$1,005.87+1.27%$1,015.00$989.77384,094 shs$110.84 billion06/04/2024$989.48$993.29+0.39%$1,000.08$986.64340,441 shs$109.45 billion06/03/2024$980.16$989.48+0.95%$1,001.04$979.26513,417 shs$109.03 billion Get the Latest News and Ratings for REGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/31/2024$969.91$980.16+1.06%$980.92$967.43812,914 shs$108.00 billion05/30/2024$966.49$969.91+0.35%$971.86$952.30443,793 shs$106.87 billion05/29/2024$973.16$966.49-0.69%$971.24$958.64345,990 shs$106.50 billion05/28/2024$985.02$973.16-1.20%$978.59$963.90336,846 shs$107.23 billion05/27/2024$985.02$985.02$995.41$983.16259,200 shs$108.54 billion05/24/2024$980.57$985.02+0.45%$995.41$983.16259,277 shs$108.54 billion05/23/2024$983.80$980.57-0.33%$991.71$975.73315,729 shs$108.05 billion05/22/2024$993.95$983.80-1.02%$997.87$981.57308,641 shs$108.40 billion05/21/2024$987.27$993.95+0.68%$995.75$982.97331,610 shs$109.52 billion05/20/2024$982.29$987.27+0.51%$987.98$978.21317,858 shs$108.79 billion05/17/2024$967.98$982.29+1.48%$982.77$966.00386,557 shs$108.24 billion05/16/2024$978.21$967.98-1.05%$978.30$967.41407,580 shs$106.66 billion05/15/2024$984.64$978.21-0.65%$988.18$966.34593,258 shs$107.79 billion05/14/2024$976.96$984.64+0.79%$987.80$970.95307,924 shs$108.50 billion05/13/2024$973.80$976.96+0.32%$982.58$970.99284,227 shs$107.23 billion05/10/2024$968.00$973.80+0.60%$979.98$966.85348,443 shs$106.89 billion05/09/2024$955.76$968.00+1.28%$969.88$956.89281,944 shs$106.25 billion05/08/2024$969.97$955.76-1.46%$971.86$952.14390,075 shs$104.91 billion05/07/2024$958.64$969.97+1.18%$970.56$957.10362,317 shs$106.46 billion05/06/2024$957.00$958.64+0.17%$962.10$950.27351,998 shs$105.22 billion05/03/2024$937.61$957.00+2.07%$958.05$926.94547,361 shs$105.04 billion05/02/2024$903.48$937.61+3.78%$943.77$891.601.07 million shs$102.91 billion05/01/2024$890.66$903.48+1.44%$913.21$888.52594,852 shs$99.17 billion04/30/2024$892.48$890.66-0.20%$896.85$885.01627,942 shs$97.76 billion04/29/2024$883.20$892.48+1.05%$897.78$883.20365,689 shs$97.96 billion04/26/2024$890.68$883.20-0.84%$887.48$875.23505,575 shs$96.94 billion04/25/2024$906.54$890.68-1.75%$915.00$876.75574,971 shs$97.76 billion04/24/2024$907.32$906.54-0.09%$915.70$904.41369,734 shs$99.50 billion04/23/2024$900.16$907.32+0.80%$912.74$903.83336,829 shs$99.59 billion04/22/2024$896.82$900.16+0.37%$908.50$897.68351,366 shs$98.80 billion04/19/2024$893.99$896.82+0.32%$920.73$891.46507,464 shs$98.43 billion04/18/2024$901.19$893.99-0.80%$908.81$892.15450,591 shs$98.12 billion04/17/2024$894.14$901.19+0.79%$911.64$899.90468,666 shs$98.91 billion04/16/2024$898.56$894.14-0.49%$901.07$890.43615,755 shs$98.14 billionShocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy.04/15/2024$904.70$898.56-0.68%$921.12$895.09656,348 shs$98.63 billion04/12/2024$920.32$904.70-1.70%$912.22$898.26665,264 shs$99.30 billion04/11/2024$936.20$920.32-1.70%$930.64$907.33617,049 shs$101.01 billion04/10/2024$943.89$936.20-0.81%$937.87$923.44389,657 shs$102.76 billion04/09/2024$938.48$943.89+0.58%$949.20$938.34305,891 shs$103.60 billion04/08/2024$942.70$938.48-0.45%$942.99$935.51330,916 shs$103.01 billion04/05/2024$937.02$942.70+0.61%$949.83$934.87363,541 shs$103.47 billion04/04/2024$950.95$937.02-1.46%$962.20$935.36396,071 shs$102.85 billion04/03/2024$954.68$950.95-0.39%$961.68$950.43413,236 shs$104.38 billion04/02/2024$969.31$954.68-1.51%$961.44$951.02434,469 shs$104.79 billion04/01/2024$962.49$969.31+0.71%$970.20$954.09347,953 shs$106.39 billion03/29/2024$962.49$962.49$970.79$959.25461,867 shs$105.64 billion03/28/2024$966.30$962.49-0.39%$970.79$959.25461,802 shs$105.64 billion03/27/2024$963.55$966.30+0.29%$976.75$962.41314,751 shs$106.06 billion03/26/2024$961.09$963.55+0.26%$966.68$957.78386,832 shs$105.76 billion03/25/2024$967.24$961.09-0.64%$964.98$952.47315,187 shs$105.49 billion03/22/2024$968.01$967.24-0.08%$977.39$966.47274,403 shs$106.16 billion03/21/2024$966.96$968.01+0.11%$979.26$968.00435,118 shs$106.25 billion03/20/2024$963.66$966.96+0.34%$967.20$947.37577,042 shs$106.13 billion03/19/2024$959.92$963.66+0.39%$969.16$959.14365,327 shs$105.77 billion03/18/2024$964.47$959.92-0.47%$970.71$959.49360,151 shs$105.36 billion03/15/2024$959.04$964.47+0.57%$968.51$953.721.08 million shs$105.86 billion03/14/2024$965.47$959.04-0.67%$969.18$950.97507,294 shs$105.26 billion03/13/2024$970.57$965.47-0.53%$979.82$963.83381,553 shs$105.97 billion03/12/2024$964.44$970.57+0.64%$975.93$963.00358,510 shs$106.53 billion03/11/2024$968.83$964.44-0.45%$979.80$960.44355,624 shs$105.86 billion Related Companies: Amgen Stock Price Chart Vertex Pharmaceuticals Stock Price Chart Gilead Sciences Stock Price Chart Biogen Stock Price Chart Alnylam Pharmaceuticals Stock Price Chart Royalty Pharma Stock Price Chart BioMarin Pharmaceutical Stock Price Chart BeiGene Stock Price Chart Neurocrine Biosciences Stock Price Chart Incyte Stock Price Chart Receive REGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:REGN) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredNVDA to close the AI “wealth window’ June 25?On Tuesday, June 25, in front of executives from nearly every major tech company in existence, key leaders at ...Paradigm Direct | SponsoredThe Greatest LEGAL Transfer of Wealth in History is UnderwayWhat's the #1 Stock to Build Generational Wealth RIGHT NOW? One Wall Street millionaire will give you a sur...Stansberry Research | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.